CDC Monthly Respiratory Bulletin for Year 2017

Year 2017-August

The influenza positivity rate in August was higher than previous month. Among all samples, 36 were positive for influenza A/H1N1 pdm 09, 25 were positive for influenza A/H3N2, 12 was positive for influenza B.  Among samples of less than 5 years patients, 14 samples positive with Respiratory Syncytial Virus (RSV) and 02 samples with hMPV and 01 sample with Adenovirus. From January to August 2017, there were E. coli detected in 7 SARI samples; Antibiotic Susceptibility testing resistance was done.  Only Meropenem is sensitise to the pathogen (100%) then follow by Chloramphenicol, Amoxicilline+Clavulanic acid, Gentamycin, Amikacin, Ciprofloxacin and Trimethoprim+Sulfamethoxazol. The E. coli is 100% resistance to Ampiciline, Cefazolin, Amoxicillin and Ceftriaxone.


Year 2017-July

The influenza positivity rate in July was higher than previous month. Among all samples, 42 were positive for influenza A/H1N1 pdm 09, 04 were positive for influenza A/H3N2, 03 was positive for influenza B/Yam and 04 were positive for influenza B/Vic. Among samples of less than 5 years patients, 07 samples positive with Respiratory Syncytial Virus (RSV) and 04 samples with Parainfluenza 3.


Year 2017-June

The influenza positivity rate in June was higher than previous month. Among all samples, 12 were positive for influenza A/H1N1 pdm 09, 07 were positive for influenza A/H3N2, 03 was positive for influenza B/Yam and 02 was positive for influenza B/Vic. Among samples of less than 5 years patients, 04 samples positive with Parainfluenza 3. In 2016 – 2017 (June), 09 SARI samples were isolated with Staphylococcus aureus.
Drug sensitivity was high with Vancomycin (100%), Trimethoprim + Sulfamethoxazole (87.5%), Tetracycline (50%), Cloxacilline (50%) Cefazolin (37.5%), Erythromycin (25%), and Clindamycin (12.5%), Oxacillin (12.5%) and No sensible to Penicillin (0%), Chloramphenicol (0%), Cephalothin (0%)


Year 2017-May

The influenza positivity rate in May was higher than previous month. Among all samples, 16 were positive for influenza A/H1N1 pdm 09, 03 were positive for influenza A/H3N2, and 01 was positive for influenza B/vic. Among samples of less than 5 years patients, 10 samples positive with Parainfluenza 3, 01 samples positive with Parainfluenza 4 and 01 samples positive with hMPV. In Jan- April 2017, 06 SARI samples were isolated with Acinetobacter species. Drug sensitivity was high with Trimethroprim + Sulfamethoxazole (66%), Gentamycin (66%), Amikacin (50%), Ceftazidine (50%), and Ciprofloxacin (50%). There was no sensible to Meropenem (0%)


Year 2017-April

The influenza positivity rate in April was higher than previous month. Among all samples, six were positive for influenza A/H1N1 pdm 09. Among samples of less than 5 years patients (46 samples), 13 samples positive with Parainfluenza 3. In Jan- April 2017, 01 SARI samples were isolated with Acinetobacter baumannii known as antimicrobial resistance bacteria. Drug sensitivity was high with Amikacin (100%) and Meropenem (100%). There was no sensible to Ceftazidine (0%), Ciprofloxacin (0%), Gentamycin (0%) and Trimethroprim + Sulfamethoxazole (0%)


Year 2017-March

The influenza positivity rate in March was lower as previous month. Among all samples, one was positive for influenza A/H1N1 pdm 09. Among samples of less than 5 years patients (16 samples), 01 sample positive with respiratory syncytial virus (RSV), 09 samples positive with Parainfluenza 3, and 01 sample positive with human Metapneumovirus (hMPV). In January and March 2017, 04 SARI samples were isolated with Streptococcus pneumoniae. The drug sensitivity was high with Vancomycin (100%) followed by Chloramphenicol (50%), Tetracycline (25%), Erythromycin (25%), Clindamycin (25%). There was no isolated pathogen sensible to Trimethroprim + Sulfamethoxazole (intermediate 25% and resistance 75%).


Year 2017-February

The influenza positivity rate in February was lower compared to previous month. Among all samples, one was positive for influenza A/H1N1 pdm 09 and one was positive Influenza B/Vic. Anong samples of less than 5 years patients, 01 respiratory syncytial virus (RSV), 08 positive with Parainfluenza 3, and 01 human Metapneumovirus (hMPV). In January and February 2017, 08 SARI sample were isolated with Pseudomonas aeruginosa. The drug sensitivity was high with Ceftazidime (100%), Ciprofloxacine (100%), Gentamycine (100%) and Amoxicllin + Clavulanic (100%).


Year 2017-January

The influenza positivity rate in December is lower compared to previous month. Influenza A was the most predominant subtype detected, followed by influenza B. 17 out of 67 samples from children less than 5 years of age were tested positive with respiratory syncytial virus (RSV). From January to December 2016, 12 SARI samples were isolated with Burkholderia pseudomallei. Drug sensitivity was high with Ceftazidime (100%), Imepenem (100%) and Amoxicillin+Clavulaic (92%).